Irritable Bowel Syndrome (IBS) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Irritable Bowel Syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs associated with a changed bowel habit for at least 3 months. This disorder is classified into three main subtypes, depending on the predominant bowel habits presented: constipation predominant IBS (IBS-C), diarrhea predominance IBS (IBS-D) and mixed presenting IBS (IBS-M).

Irritable Bowel Syndrome (IBS) market size is projected to reach US$ 10960 million by 2026, from US$ 4130.9 million in 2019, at a CAGR of 15% during 2021-2027.

The following players are covered in this report:

• Bausch Health
• Allergan
• Takeda
• Sucampo Pharmaceuticals (Mallinckrodt)
• Sebela Pharmaceuticals Inc.
• Astellas Pharmaceuticals

Irritable Bowel Syndrome (IBS) Breakdown Data by Type

• IBS-D Drug
• IBS-C Drug
• Others

Irritable Bowel Syndrome (IBS) Breakdown Data by Application

• Women
• Men

Scope of the Report

The research study analyzes the global Irritable Bowel Syndrome (IBS) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Irritable Bowel Syndrome (IBS) Market Report

1. What was the Irritable Bowel Syndrome (IBS) Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of Irritable Bowel Syndrome (IBS) Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Irritable Bowel Syndrome (IBS) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.